Stock data
Moleculin Biotech, Inc. (MBRX)
Moleculin Biotech, Inc. (MBRX) reported revenue of US$0.00M and net income of -US$33.56M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.00M | — | -US$25.10M | -US$33.56M | — |
| 2024 | US$0.00M | — | -US$26.64M | -US$26.05M | — |
| 2023 | US$0.00M | — | -US$29.63M | -US$29.77M | — |
| 2022 | US$0.00M | — | -US$30.64M | -US$29.02M | — |
| 2021 | US$0.00M | — | -US$22.97M | -US$15.89M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.00M | -US$7.63M | — |
| 2026-03-31 | US$0.00M | -US$12.85M | — |
| 2025-12-31 | US$0.00M | US$15.55M | — |
| 2025-09-30 | US$0.00M | -US$25.40M | — |
| 2025-06-30 | US$0.00M | -US$17.81M | — |
| 2025-03-31 | US$0.00M | -US$5.90M | — |
| 2024-12-31 | US$0.00M | -US$6.58M | — |
| 2024-09-30 | US$0.00M | -US$7.02M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.